Cathlab Forum | tctmd.com
Hub page
Related Articles
Global Commission Proposes ‘Radical’ Overhaul of Obesity Diagnosis
The two-tiered classification focuses on preclinical and clinical stages of disease, and should help inform treatment decisions.
FDA Proposes Simplified Front-of-Package Nutrition Labels on Foods
The aim is to make it easier for consumers to determine how much saturated fat, sodium, and added sugar are inside.
CMS Opens Coverage Analysis for Renal Denervation
Public comments will be accepted for 30 days. A final coverage decision is expected in October 2025.
Home | CTO 2025
99% CTO Plus 2024 program exceeded or met professional expectatio ns. 95% Extremely or very confident of applying conference learnings in practice decisions and clinical…
Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates
Even in sub-Saharan Africa, one of the last bastions untouched by Western diets, sugar-sweetened drinks are fueling disease.
Patient Experience Worsens When Private Equity Firms Acquire US Hospitals
Greater transparency, monitoring, and regulatory oversight are needed around these transactions, a researcher says.
Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit
The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.
Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain
The findings represent the first step to potentially augmenting current risk models with Lp(a) measurements, the author says.
Top Policy and Practice News of 2024
Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in cardiology this year.
Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.